Omnaris

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Ciclesonide 50ug (per actuation)

Available from:

Chiesi New Zealand Limited t/a Emerge Health

INN (International Name):

Ciclesonide 50 µg (per actuation)

Dosage:

50 mcg/dose

Pharmaceutical form:

Nasal spray solution

Composition:

Active: Ciclesonide 50ug (per actuation) Excipient: Carmellose sodium Disodium edetate Hydrochloric acid Hypromellose Microcrystalline cellulose Nitrogen Potassium sorbate Purified water

Units in package:

Inhaler, metered, Glass bottle with metered dose pump, 60 dose units

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Dynamit Nobel GmbH

Therapeutic indications:

Omnaris® Nasal Spray is indicated for the treatment of seasonal allergic rhinitis in adults and children 6 years of age and older.

Product summary:

Package - Contents - Shelf Life: Inhaler, metered, Glass bottle with metered dose pump - 60 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified - Inhaler, metered, Glass bottle with metered dose pump - 120 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified

Authorization date:

2010-06-28